EUVIMEDEUVIMED entdecken
Crossref

Potential use of bitter melon (Momordica charantia) derived compounds as antidiabetics: In silico and in vivo studies

Olusola Olalekan Elekofehinti, Esther Opeyemi Ariyo, Moses Orimoloye Akinjiyan, Olanrewaju Sam Olayeriju, Akeem Olalekan Lawal, Isaac Gbadura Adanlawo, Joao Batista Teixeira Rocha

Pathophysiology · 2018-12 · 25 (4) · 327-333

DOI: 10.1016/j.pathophys.2018.05.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathophysiology, 2018-12. Verfasst von Olusola Olalekan Elekofehinti und 6 weiteren Autor:innen. Beteiligte Einrichtung: Bioinformatics and Molecular Biology Units, Department of Biochemistry, Federal University of Technology, Akure, Nigeria. Electronic address: ooeleko…. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Bitter lemonDPP4Gene expressionGlp-1Molecular dockingTGR5

Autor:innen und Institutionen

  • Bioinformatics and Molecular Biology Units, Department of Biochemistry, Federal University of Technology, Akure, Nigeria. Electronic address: ooelekofehinti@futa.edu.ng.
  • Bioinformatics and Molecular Biology Units, Department of Biochemistry, Federal University of Technology, Akure, Nigeria.
  • Ekiti State University, Ado Ekiti, Nigeria.
  • Bioquimica Toxicologia, Departmento de Quimica, CCNE, Universidade Federal de Santa Maria, RS, 97105-900 Brazil.

Zitieren

APA

Elekofehinti, O. O., Ariyo, E. O., Akinjiyan, M. O., Olayeriju, O. S., Lawal, A. O., Adanlawo, I. G., & Rocha, J. B. T. (2018). Potential use of bitter melon (Momordica charantia) derived compounds as antidiabetics: In silico and in vivo studies. Pathophysiology, 25(4), 327-333. https://doi.org/10.1016/j.pathophys.2018.05.003

Vancouver

Elekofehinti OO, Ariyo EO, Akinjiyan MO, Olayeriju OS, Lawal AO, Adanlawo IG, et al. Potential use of bitter melon (Momordica charantia) derived compounds as antidiabetics: In silico and in vivo studies. Pathophysiology. 2018;25(4):327-333. doi:10.1016/j.pathophys.2018.05.003

BibTeX
@article{Elekofehinti2018,
  author = {Elekofehinti, Olusola Olalekan and Ariyo, Esther Opeyemi and Akinjiyan, Moses Orimoloye and Olayeriju, Olanrewaju Sam and Lawal, Akeem Olalekan and Adanlawo, Isaac Gbadura and Rocha, Joao Batista Teixeira},
  title = {Potential use of bitter melon (Momordica charantia) derived compounds as antidiabetics: In silico and in vivo studies},
  journal = {Pathophysiology},
  year = {2018},
  volume = {25},
  number = {4},
  pages = {327--333},
  doi = {10.1016/j.pathophys.2018.05.003}
}
Kostenlos starten →